Pure Bioscience, Inc.
PURE· OTC
PUREPure Bioscience, Inc.
Filed Feb 25, 2013 · 10-Q · 25 days after period end · 0001079973-13-000134
| Metric | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|
| Revenue | $263.00K | $221.00K | $68.00K |
| Net Income | -$1.82M | -$2.19M | -$2.48M |
| EPS Diluted | -$0.17 | -$0.41 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
ended Jan 31, 2013 · filed Feb 25, 2013 · 25 d after period end
